Cartilage Repair Market to hit US$ 2,956.67 million by 2030 | Exclusive Report by Growth Plus Reports

Pune, Dec. 21, 2022 (GLOBE NEWSWIRE) — As per the report published by Growth Plus Reports the Global Cartilage Repair Market was estimated at US$ 850.4 million in 2021 and is expected to surpass a valuation of US$ 2,956.67 million by 2030, progressing at a CAGR of 14.85% from 2022 to 2030. The report provides a detailed analysis of top winning strategies, drivers & opportunities, competitive scenario, wavering market trends, market size, statistics & estimations, and major investment pockets. Rising healthcare standards and an increase in sports-related injuries contribute to the significant rise of the global cartilage repair market.

The global cartilage repair market has been analyzed from three perspectives: treatment modality, treatment type, application, and region.

Download PDF Brochure of Cartilage Repair Market Size – COVID-19 Impact and Global Analysis with Strategic Developments at:

A growing geriatric population, rising obesity rates, rising healthcare costs, and an increase in sports-related injuries are driving the rise of the global cartilage repair market. The market is also expanding due to the rise in cutting-edge product introductions and the expansion of medical tourism, both raising awareness of cartilage treatment options worldwide. Due to the long-term effectiveness, the cell-based treatments segment is predicted to grow faster during the forecast period.

Excerpts from ‘by Modality’ 

The global cartilage repair market is segmented based on modality into:

  • Cell-Based
  • Non-Cell-Based Treatments

The cell-based treatment segment is further classified into growth factor technology and chondrocyte transplantation. Tissue scaffolds and cell-free composites are the non-cell-based modalities. Cell-based treatment regenerates tissue, which fosters its ability to heal. The demand for cell-based treatment is increasing as it is a minimally invasive procedure. Tissue scaffold-based non-cell therapy is highly used in non-cell-based modalities. Scaffolds, often comprised of polymeric biomaterials, give cells the structural support they need to connect, allowing for the fast formation of new tissue.

Excerpts from ‘by Treatment Type’

The global cartilage repair market is divided into:

  • Palliative
  • Intrinsic Treatments

The palliative treatment segment is divided into debridement & lavage, and viscosupplementation. The intrinsic treatments segment has dominated the market. Intrinsic cartilage repair improves pain control over the long term. This in turn, increases its demand. Also, Intrinsic cartilage repair offers multilineage potential and proliferative capacity. In the palliative treatment segment viscosupplementation segment is dominating.

Excerpts from ‘by Application’

According to application, the global cartilage repair market is grouped into:

  • Fibrocartilage
  • Hyaline Cartilage Repair

The hyaline cartilage repair segment has dominated the market. Due to the high incidence of hyaline cartilage injuries, the demand for the complementary treatment is high, contributing to the more outstanding market share. Additionally, rising sports-related injuries cause knee and other joint articular cartilage abnormalities, which is anticipated to promote segment expansion.

Excerpts from ‘By Region’

Regionally, the global cartilage repair market has been segmented into:

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

North America has been the largest market for cartilage repair because of the rising prevalence of obesity, growing healthcare expenditure, improving awareness, and easy access to innovative cartilage repair and regeneration technologies. The United States contributes to the largest revenue share globally. The U.S. cartilage repair industry is primarily driven by the high incidence of sports injuries and the aging population. Europe is the second largest market, driven by rising demand for cell-based methods, rising healthcare costs, and swift approval of new products. Germany dominated the European cartilage repair market and shall continue to lead during the projection period. Asia Pacific is predicted to experience the fastest growth in the global cartilage repair market during the forecast period, which can be attributed to the region’s rising per capita income, rising healthcare spending, growing demand for higher-quality medical care, and increasing awareness of cartilage repair therapies.

Request for Customization –

Excerpts from ‘Competitive Landscape’

Some prominent players operating in the global cartilage repair market are:

  • DePuy Synthes
  • Smith & Nephew plc
  • Zimmer Biomet
  • Stryker Corporation
  • Vericel Corporation
  • CONMED Corporation
  • Collagen Solutions Plc
  • Arthrex, Inc.
  • Anika Therapeutics Inc.
  • B. Braun Melsungen AG

Table of Content

    1. Market Ecosystem 
    2. Timeline Under Consideration
      1. Historical Years – 2020 
      2. Base Year – 2021
      3. Forecasted Years – 2022 to 2030
    3. Currency Used in the Report
    1.    Research Approach
    2. Data Collection Methodology
    3. Data Sources
      1. Secondary Sources 
      2. Primary Sources 
    4. Market Estimation Approach
      1. Bottom Up 
      2. Top Down 
    5. Market Forecasting Model
    6. Limitations and Assumptions       
    1. Current Market Trend (COVID-19 Perspective)
    2. Key Players & Competitive Positioning (2021) 
    1. Drivers
    2. Restraints
    3. Opportunities
    1. Cell-Based 
      1. Growth Factor Technology 
      2. Chondrocyte Transplantation 
    2. Non-Cell Based 
      1. Tissue Scaffolds
      2. Cell-Free Composites 
    1. Palliative 
      1. Debridement & Lavage 
      2. Viscosupplementation 
    2. Intrinsic Repair Stimulus 
    1. Fibrocartilage
    2. Hyaline Cartilage 

TOC Continued….


  • Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
  • Comprehensive quantitative and qualitative insights at segment and sub-segment level
  • Covid 19 impact trends and perspective
  • Granular insights at global/regional/country level
  • Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
  • Blanket coverage on competitive landscape
  • Winning imperatives
  • Exhaustive coverage on ‘Strategic Developments’ registered by leading players of the market


  • Distributor Landscape Assessment
  • Pricing Intelligence
  • Customer Base Assessment
  • Investment & Initiatives Analysis
  • ‘Business Profile’ of Key Players

Inquiry Before Buying:

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as “Most Innovative Healthcare Market Research Company in 2020.


Manan Sethi
Director, Market Insights
Email: [email protected]
Phone no: +91 96545 76783
Follow Us: LinkedIn | Twitter

CONTACT: Manan Sethi Director, Market Insights Email: [email protected] Phone no: +91 96545 76783 Web: 

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. takes no editorial responsibility for the same.